Bevacizumab (B) in the adjuvant treatment of breast cancer - first toxicity results from Eastern Cooperative Oncology Group trial E5103.

Saved in:
Bibliographic Details
Title: Bevacizumab (B) in the adjuvant treatment of breast cancer - first toxicity results from Eastern Cooperative Oncology Group trial E5103.
Authors: Miller, K. D., O'Neill, A., Dang, C., Northfelt, D., Gradishar, W., Sledge, G. W.
Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p1605-1606. 2p.
Database: Academic Search Ultimate
Description
ISSN:00085472
DOI:10.1158/0008-5472.SABCS12-P5-17-01